14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CERU
Delisted

Cerulean Pharma Inc. Fund Signals

$0.660
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 64 days ( 14.29 % )
Last Price $0.660 0 %
High/ Low $0.660 - $0.660 0%
Chg 7 Days N/A $0.660 $0.660
Chg 30 Days N/A $0.660 $0.660
Chg 12 mos -21.43 % $0.84 $0.660
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -19.80 % Width: 436.26 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos N/A - $2.24 -100.00 % - 238.80 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Buy Dec 01, 2017 - 30 days
Short/Long MA avg 3 mos Buy Dec 01, 2017 - 30 days
Short MA avg 12 mos Buy Jul 31, 2017 - 51 days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Jan 15, 2018 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Cerulean Pharma Inc.

Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The company’s lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301... CERU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT